跳至主要内容
临床试验/EUCTR2008-005609-21-DE
EUCTR2008-005609-21-DE进行中(未招募)不适用

Exploratory study to assess the predictive value of 99mTc-labeled albumin spheres for the intrahepatic distribution of 90Y SIR Spheres in patients with liver metastases of colorectal tumors. - Explosive

Faculty For Medicine, Otto-von-Guericke University Magdeburg0 个研究点开始时间: 2009年6月3日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.age: between 18 and 85 years
  • 2.if female, postmenopausal or surgically sterilized
  • 3.liver metastases of a colorectal tumor in both liver lobes
  • 4.scheduled for therapy with 90Y SIR spheres for clinical reasons
  • 5.life expectancy longer than 6 months
  • 6.willing and able to undergo all study procedures
  • 7.having voluntarily provided written and fully informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.presenting with a contraindication to 90Y SIR spheres therapy
  • 2.variants of the arterial hepatic blood supply which interfere with the objectives of this study (e.g., variants of Michel)
  • 3.women who are pregnant, lactating or who are of childbearing potential
  • 4.patients being clinically unstable
  • 5.uncooperative, in the investigator’s opinion
  • 6.any contraindication to SIRT treatment
  • 7.any concomitant chemotherapy
  • 8.shunt to the lung >10%
  • 9.shunt to any extrahepatic organ (except the lung)
  • 10.having been previously enrolled in this study
  • 11.participating in another clinical trial

研究者

发起方
Faculty For Medicine, Otto-von-Guericke University Magdeburg

相似试验

Exploratory study to assess the predictive value of... | 临床试验